During the past decade, Royal Marsden - Surrey conducted 329 clinical trials. In the 10-year time frame, 329 clinical trials started and 113 clinical trials were completed, i.e. on average, 34.3% percent of trials that started reached the finish line to date. In the past 5 years, 138 clinical trials started and 81 clinical trials were completed. i.e. 58.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Marsden - Surrey" #1 sponsor was "Royal Marsden NHS Foundation Trust" with 98 trials, followed by "Institute of Cancer Research, United Kingdom" with 46 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 31 trials sponsored, "Children's Cancer and Leukaemia Group" with 30 trials sponsored and "Hoffmann-La Roche" with 30 trials sponsored. Other sponsors include 378 different institutions and companies that sponsored additional 155 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Marsden - Surrey" #1 collaborator was "Cancer Research UK" with 22 trials as a collaborator, "Institute of Cancer Research, United Kingdom" with 17 trials as a collaborator, "Royal Marsden NHS Foundation Trust" with 15 trials as a collaborator, "Merck Sharp & Dohme LLC" with 12 trials as a collaborator and "AstraZeneca" with 10 trials as a collaborator. Other collaborators include 297 different institutions and companies that were collaborators in the rest 207 trials.

According to Clinical.Site data, the most researched conditions in "Royal Marsden - Surrey" are "Breast Cancer" (40 trials), "Prostate Cancer" (33 trials), "Multiple Myeloma" (28 trials), "Ovarian Cancer" (28 trials) and "Cancer" (25 trials). Many other conditions were trialed in "Royal Marsden - Surrey" in a lesser frequency.

Most popular intervention types in "Royal Marsden - Surrey" are "Drug" (470 trials), "Procedure" (84 trials), "Radiation" (75 trials), "Other" (73 trials) and "Biological" (63 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (50 trials), "radiation therapy" (47 trials), "carboplatin" (29 trials), "cisplatin" (27 trials) and "adjuvant therapy" (24 trials). Other intervention names were less common.

The vast majority of trials in "Royal Marsden - Surrey" are 488 trials for "All" genders, 70 trials for "Female" genders and 57 trials for "Male" genders.

Currently, there are 191 active trials in "Royal Marsden - Surrey". 2 are not yet recruiting, 111 are recruiting, 77 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 248 completed trials in Royal Marsden - Surrey, 1 suspended trials, and 49 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Marsden - Surrey, 145 "Phase 1" clinical trials were conducted, 216 "Phase 2" clinical trials and 208 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 44 trials that are defined as “Not Applicable".